MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Genkyotex Raises CHF25 Million in Series C Round Extension.
Guest UserJuly 9, 2012
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Genocea Initiates a Phase 1/2a Study with its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2).

Guest UserAugust 15, 2012
Next

Pronota's Risk Stratification Test Breaks New Ground in the Early Detection of Pre-term Pre-eclampsia.

Guest UserJuly 9, 2012

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact